| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |